Sartorius wins double award at Fisher Scientific European Sales Conference for the second time

Sartorius, a leading international partner of biopharmaceutical research and the industry, was once again a double award winner at the Fisher Scientific European Sales Conference in Karpacz, Poland, retaining the same awards won in 2018, European Excellence and Supplier Best Booth.

Sartorius wins double award at Fisher Scientific European Sales Conference

The European Excellence Award recognized the cooperation between Fisher Scientific and Sartorius. The award was presented by Anke Schimko, Vice President Portfolio Management, at Fisher Scientific.

This supplier has constantly performed at a high level, working with our Sales and Portfolio Management teams to embrace all the elements of our new Supplier Tiering Programme and ensured they immediately achieved Tier 1 Status.

They have a strong and knowledgeable Channel Management team that enjoys direct integration with our Key Account and Marketing teams. This supplier is set for an even greater performance in 2019.”

Anke Schimko, Vice President Portfolio Management, Fisher Scientific

In addition to the European Excellence Award, Sartorius also won Supplier Best Booth award once again. This award is voted by the Fisher Scientific Commercial team and recognized the supplier whose booth best incorporates the four values of Fisher Scientific: involvement, intensity, innovation and integrity.

John Bryson, Head of Channel Management at Sartorius, accepted the awards:

Repeating last year’s success is a remarkable achievement for the team and reflects the excellent strategic collaboration we have with Fisher Scientific. 2019 will be another big year for our relationship as we launch major new products and continue to partner together to drive success.”

John Bryson


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Sartorius Stedim Biotech and Repligen collaborate to create novel perfusion-enabled bioreactors